Description
Isotonitazene (citrate) (Item No. 40425) is an analytical reference standard categorized as an opioid.1,2,3 Isotonitazene has analgesic effects in mice.4 It has been associated with overdoses.5 Isotonitazene is regulated as a Schedule I compound in the United States. This product is intended for research and forensic applications.WARNING This product is not for human or veterinary use.
References
[1] A. F. CASY J. W. Ionisation constants and partition coefficients of some analgesically active 2-benzylbenzimidazole derivatives and related compounds[J]. Journal of Pharmacy and Pharmacology, 1966, 18 10: 677-683. DOI:
10.1111/j.2042-7158.1966.tb07782.x[2] PETER BLANCKAERT. Report on a novel emerging class of highly potent benzimidazole NPS opioids: Chemical and in vitro functional characterization of isotonitazene[J]. Drug Testing and Analysis, 2019, 12 4: 422-430. DOI:
10.1002/dta.2738[3] MARTHE M. VANDEPUTTE. Synthesis, Chemical Characterization, and μ-Opioid Receptor Activity Assessment of the Emerging Group of “Nitazene” 2-Benzylbenzimidazole Synthetic Opioids.[J]. ACS Chemical Neuroscience, 2021. DOI:
10.22541/au.160520665.59016513/v2[4] ISTVÁN UJVÁRY*. DARK Classics in Chemical Neuroscience: Etonitazene and Related Benzimidazoles[J]. ACS Chemical Neuroscience, 2021, 12 7: 1072-1092. DOI:
10.1021/acschemneuro.1c00037[5] CHELSEA L SHOVER. Emerging Characteristics of Isotonitazene-Involved Overdose Deaths: A Case-Control Study.[J]. Journal of Addiction Medicine, 2021, 15 5: 429-431. DOI:
10.1097/adm.0000000000000775[6] LAURA B KOZELL. Pharmacologic Characterization of Substituted Nitazenes at μ, κ, and Δ Opioid Receptors Suggests High Potential for Toxicity.[J]. Journal of Pharmacology and Experimental Therapeutics, 2024: 219-228. DOI:
10.1124/jpet.123.002052